Evidence map›Paper›PMID 37942563›Full record

ArticleHuman vaccines & immunotherapeutics2023

"Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials".

Monica Anne McArthur, Siham Bchir, Estelle Dubois, Lucia Gan, Eric Gerchman, Sandeep Gupta, Olga Liabis, Lucia Perez, Fabienne Roche, Gustavo Vasquez and 3 more

Open access · goldAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Monica Anne McArthurGlobal Clinical Development Strategy, Sanofi, Swiftwater, PA, USA.
Siham BchirGlobal Biostatistical Sciences, Sanofi, Marcy l'Etoile, France.
Estelle DuboisGlobal Clinical Operations, Sanofi, Marcy l'Etoile, France.
Lucia GanGlobal Biostatistical Sciences, Sanofi, Swiftwater, PA, USA.
Eric GerchmanGlobal Clinical Operations, Sanofi, Swiftwater, PA, USA.
Sandeep GuptaGlobal Clinical Development Strategy, Sanofi, Swiftwater, PA, USA.
Olga LiabisGlobal Clinical Development Strategy, Sanofi, Marcy l'Etoile, France.
Lucia PerezGlobal Clinical Operations, Sanofi, Swiftwater, PA, USA.
Fabienne RocheGlobal Clinical Operations, Sanofi, Marcy l'Etoile, France.
Gustavo VasquezGlobal Clinical Development Strategy, Sanofi, Swiftwater, PA, USA.
Betzana ZambranoGlobal Clinical Development Strategy, Sanofi, Montevideo, Uruguay.
Sanjay GurunathanGlobal Clinical Development Strategy, Sanofi, Swiftwater, PA, USA.
Mandeep Singh DhingraGlobal Clinical Development Strategy, Sanofi, Swiftwater, PA, USA.
Sanofi (United States) · USSanofi (France) · FRBiostatistical Consulting (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus 2019 (COVID-19) pandemic, as well as the resulting public health measures, impacted many aspects of society. The conduct of important pediatric vaccine trials was among these. Analyzing data from six ongoing non-COVID-19 pediatric vaccine trials we aimed to assess the operational impact of the COVID-19 pandemic using descriptive analyses. We identified multiple operational disruptions in trial conduct. Additionally, we identified higher percentages of missed routine vaccinations than investigational vaccines throughout the observation period. Overall, the impact of the COVID-19 pandemic was most apparent early in the pandemic period while adaptations to the pandemic were developed; however, some disruptions persisted throughout the observation period. Pediatric vaccine clinical trials are critical to developing new and/or improved vaccines for the pediatric population. Continued evaluation of the impacts of COVID-19 on pediatric vaccine clinical trials is warranted.

Indexed as

COVID-19VaccinesChildHumansPandemicsPublic HealthVaccinationVaccinesclinical trials operationsCOVID-19operational disruptionpediatric vaccine trialsVaccines

Identifiers

PMID37942563
PMCPMC10653681
OpenAlexW4388533508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.